| Literature DB >> 25821791 |
Yue Jin1, Guohao Xie1, Haihong Wang2, Lielie Jin3, Jun Li4, Baoli Cheng1, Kai Zhang1, Andreas Hoeft5, Xiangming Fang1.
Abstract
PURPOSE: To assess the incidence of postoperative pulmonary complications (PPCs) in Chinese inpatients, and to develop a brief predictive risk index.Entities:
Mesh:
Year: 2015 PMID: 25821791 PMCID: PMC4363533 DOI: 10.1155/2015/265165
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Definitions of postoperative pulmonary complications.
|
| |
| Treatment with antibiotics for a respiratory infection, plus at least one of the following criteria: new or changed sputum, new or changed lung opacities, fever, and leukocyte count >12,000/mm3 | |
|
| |
|
| |
| Postoperative PaO2 <60 mmHg on room air, a ratio of PaO2 to inspired oxygen fraction <300, or SaO2 <90% and requiring oxygen therapy | |
|
| |
|
| |
| Chest radiograph demonstrating blunting of the costophrenic angle, evidence of displacement of adjacent anatomical structures, or (in supine position) a hazy opacity in one hemithorax with preserved vascular shadows | |
|
| |
|
| |
| Collapse of the alveoli, lung opacification with shift of the mediastinum, hilum, or hemidiaphragm toward the affected area, and compensatory overinflation in the adjacent nonatelectatic lung | |
|
| |
|
| |
| A collection of air in the pleural space (the area with no vascular bed surrounding the visceral pleura) | |
|
| |
|
| |
| Newly detected expiratory wheezing treated with bronchodilators | |
|
| |
|
| |
| Acute lung injury after the inhalation of regurgitated gastric contents | |
PaO2: partial pressure of oxygen in arterial blood; SaO2: arterial oxyhemoglobin saturation.
Figure 1Flow-chart of study population. LOS: the length of stay.
Demographic and clinical characteristics.
| Overall | Cohort 1 | Cohort 2 |
| |
|---|---|---|---|---|
| ( | ( | ( | ||
| Male, | 770 (46.0) | 436 (48.3) | 334 (43.3) | 0.04 |
| Age, yr | 49 (37–60) | 48 (36–60) | 49 (39–60) | 0.69 |
| Education, yr | 9 (6–9) | 9 (6–9) | 9 (9–14.5) | 0.31 |
| Smoking status, | 0.85 | |||
| Never smoker | 1397 (83.5) | 753 (83.5) | 644 (83.5) | |
| Former smoker | 222 (13.3) | 118 (13.1) | 104 (13.5) | |
| Current smoker | 54 (3.2) | 31 (3.4) | 23 (3.0) | |
| Drinker, | 0.47 | |||
| Never drinker | 1487 (88.9) | 804 (89.1) | 683 (88.6) | |
| Former drinker | 152 (9.1) | 83 (9.2) | 69 (8.9) | |
| Current drinker | 34 (2.0) | 15 (1.7) | 19 (2.5) | |
| Body mass index, kg/m2 | 22.3 (20.3–24.3) | 22.1 (20.3–24. 2) | 22.4 (20.3–24.3) | 0.85 |
| Preoperative SpO2, % | 98 (98-99) | 98 (98-99) | 98 (98-98) | 0.45 |
| Respiratory infection in the last month, | 28 (1.7) | 16 (1.8) | 12 (1.6) | 0.85 |
| ASA physical status, | 0.43 | |||
| 1 | 830 (49.6) | 464 (51.4) | 366 (47.5) | |
| 2 | 722 (43.2) | 380 (42.1) | 342 (44.4) | |
| 3 | 114 (6.8) | 54 (6.0) | 60 (7.8) | |
| 4 | 5 (0.3) | 3 (0.3) | 2 (0.3) | |
| 5 | 2 (0.1) | 1 (0.1) | 1 (0.1) | |
| Emergency surgery, | 102 (6.1) | 55 (6.1) | 47 (6.1) | 0.99 |
| Anesthesia, | 0.24 | |||
| General and combined# | 1251 (74.8) | 664 (73.6) | 587 (76.1) | |
| Neuraxial/regional | 422 (25.2) | 238 (26.4) | 184 (23.9) | |
| Surgical site, | <0.001 | |||
| Peripheral | 1015 (60.7) | 620 (68.7) | 395 (51.2) | |
| Abdominal | 600 (35.9) | 243 (26.9) | 357 (46.3) | |
| Intrathoracic | 58 (3.5) | 39 (4.3) | 19 (2.5) | |
| Duration of surgery, h | 0.63 | |||
| ≤2 h | 1238 (74.0) | 659 (73.1) | 579 (75.1) | |
| 2-3 h | 235 (14.0) | 132 (14.6) | 103 (13.4) | |
| >3 h | 200 (12.0) | 111 (12.3) | 89 (11.5) | |
| LOS, d | 8 (5–14) | 9 (6–14) | 8 (5–13) | 0.01 |
Data are median (quartile) unless otherwise specified.
SpO2: saturation of peripheral oxygen; ASA: American society of anesthesiologists; LOS: length of stay.
*Cohort 1 versus cohort 2; #this category included general anesthesia alone and general anesthesia combined with regional blockade.
Incidence of PPCs with LOS according to surgical specialties.
| All patients | PPCs, | LOS (day) |
| ||
|---|---|---|---|---|---|
| With PPCs ( | Without PPCs ( | ||||
| Total | 1673 | 163 (9.7) | 16 (10–23) | 8 (5–13) | <0.001 |
| Surgical specialty | |||||
| Orthopaedics | 303 | 10 (3.3) | 22 (14–31) | 11 (6–17) | 0.03 |
| Breast | 72 | 2 (2.8) | 20 (19–21) | 4 (3–8) | <0.001 |
| Gynaecology | 208 | 16 (7.7) | 10 (7–19) | 6 (4–8) | <0.001 |
| Vascular | 33 | 1 (3.0) | 16 (16–16) | 9 (7–13) | 0.45 |
| Upper gastrointestinal | 47 | 19 (40.4) | 18 (16–21) | 17 (13–20) | 0.68 |
| Lower gastrointestinal | 136 | 16 (11.8) | 17 (15–28) | 11 (6–15) | <0.001 |
| Hepatobiliary | 229 | 31 (13.5) | 24 (16–33) | 8 (5–14) | <0.001 |
| Urology | 168 | 7 (4.2) | 16 (13–38) | 8 (6–11) | 0.16 |
| Kidney | 56 | 8 (14.3) | 13 (10–17) | 10 (7–14) | 0.65 |
| Head and neck | 147 | 9 (6.1) | 4 (3–7) | 7 (5–9) | 0.21 |
| Thoracic | 49 | 19 (38.8) | 12 (10–15) | 14 (9–16) | 0.36 |
| Neurosurgery | 36 | 8 (22.2) | 22 (12–27) | 18 (12–25) | 0.40 |
| Endocrinology | 147 | 14 (9.5) | 8 (7–14) | 7 (6–8) | 0.11 |
| Others | 41 | 4 (2.4) | 10 (7–26) | 7 (5–9) | 0.16 |
Data are median (quartile) unless otherwise specified.
PPCs: postoperative pulmonary complications; LOS: length of stay.
Distribution of results of independent variables in cohort 1.
| Number of patients | Number (%) of patients with PPCs |
| |
|---|---|---|---|
| Age, yr | <0.001 | ||
| <59 | 670 | 65 (9.7) | |
| ≥60 | 232 | 47 (20.3) | |
| ASA physical status | <0.001 | ||
| 1 | 464 | 20 (4.3) | |
| 2 | 380 | 77 (20.3) | |
| 3 | 54 | 13 (24.1) | |
| 4 | 3 | 1 (33.3) | |
| 5 | 1 | 1 (100.0) | |
| Smokers | 0.001 | ||
| No | 753 | 79 (10.5) | |
| Yes | 149 | 33 (22.1) | |
| Respiratory infection in the last month | <0.001 | ||
| No | 886 | 101 (11.4) | |
| Yes | 16 | 11 (68.8) | |
| Diabetes | 0.001 | ||
| No | 846 | 97 (11.5) | |
| Yes | 56 | 15 (26.8) | |
| COPD | <0.001 | ||
| No | 890 | 106 (11.9) | |
| Yes | 12 | 6 (50.0) | |
| Cirrhosis | 0.014 | ||
| No | 895 | 109 (12.2) | |
| Yes | 7 | 3 (42.9) | |
| Stroke/transient ischaemic attack | 0.001 | ||
| No | 887 | 106 (12.0) | |
| Yes | 15 | 6 (40.0) | |
| Preoperative antibiotic use | <0.001 | ||
| No | 298 | 19 (6.4) | |
| Yes | 604 | 93 (15.4) | |
| Preoperative SpO2, % | <0.001 | ||
| ≥96 | 845 | 92 (10.9) | |
| <96 | 57 | 20 (35.1) | |
| Preoperative anemia | 0.007 | ||
| No | 837 | 97 (11.6) | |
| Yes | 65 | 15 (23.1) | |
| Preoperative LOS, d | 0.002 | ||
| <2 | 126 | 5 (4.0) | |
| ≥2 | 776 | 107 (13.8) | |
| Surgery site | <0.001 | ||
| Peripheral | 620 | 36 (5.8) | |
| Abdominal | 243 | 56 (23.0) | |
| Intrathoracic | 39 | 20 (51.3) | |
| Anesthesia | <0.001 | ||
| Regional | 238 | 10 (4.2) | |
| General | 664 | 102 (15.4) | |
| Intraoperative nasogastric tube | <0.001 | ||
| No | 847 | 85 (10.0) | |
| Yes | 55 | 27 (49.1) | |
| Intraoperative bladder catheter | <0.001 | ||
| No | 466 | 28 (6.0) | |
| Yes | 436 | 84 (19.3) | |
| Intraoperative central venous catheter | <0.001 | ||
| No | 821 | 85 (10.4) | |
| Yes | 81 | 27 (33.3) | |
| Intraoperative blood loss, mL | <0.001 | ||
| <100 | 636 | 32 (5.0) | |
| ≥100 | 266 | 80 (30.1) | |
| Intraoperative blood transfusion | <0.001 | ||
| No | 875 | 102 (11.7) | |
| Yes | 27 | 10 (37.0) | |
| Duration of surgery, h | <0.001 | ||
| ≤2 h | 659 | 47 (7.1) | |
| >2 to 3 h | 132 | 27 (20.5) | |
| >3 h | 111 | 38 (34.2) | |
| Postoperative SpO2, % | <0.001 | ||
| ≥96 | 891 | 101 (11.3) | |
| <96 | 11 | 11 (100.0) | |
| Postoperative leucocyte, 109/L | <0.001 | ||
| <4 | 6 | 2 (33.3) | |
| 4–10 | 665 | 47 (7.1) | |
| >10 | 231 | 63 (27.3) | |
| Postoperative anemia | 0.009 | ||
| No | 793 | 90 (11.3) | |
| Yes | 109 | 22 (20.2) | |
| Postoperative fasting blood glucose, mmol/L | <0.001 | ||
| ≤6.1 | 778 | 50 (6.4) | |
| >6.1 | 124 | 62 (50.0) | |
| Postoperative creatinine, | <0.001 | ||
| ≤115 | 872 | 99 (11.4) | |
| >115 | 30 | 13 (43.3) | |
| Postoperative albumin, g/L | <0.001 | ||
| <35 | 244 | 85 (34.8) | |
| ≥35 | 658 | 27 (4.1) | |
| Postoperative ventilation | <0.001 | ||
| No | 878 | 97 (11.0) | |
| Yes | 24 | 15 (62.5) | |
| Postoperative vasoactive drug | <0.001 | ||
| No | 893 | 105 (11.8) | |
| Yes | 9 | 7 (77.8) |
Smoking: defined as patients who smoked up to 1 year before surgery; Anemia: defined as hemoglobin <100 g/L.
PPCs: postoperative pulmonary complications; ASA: American society of anesthesiologists; COPD: chronic obstructive pulmonary disease; SpO2: saturation of peripheral oxygen; LOS: length of stay.
Independent predictors of risk factors for PPCs.
| OR (95% CI) |
| Risk score | |
|---|---|---|---|
| Respiratory infection in the last month | 7.03 (1.66–29.80) | 1.950 | 20 |
| Smokers | 2.37 (1.27–4.42) | 0.861 | 9 |
| Preoperative antibiotic use | 0.238 (0.11–0.54) | −1.436 | −14 |
| Preoperative SpO2 <96% | 5.56 (2.38–12.98) | 1.715 | 17 |
| Surgery site | |||
| Peripheral | 1 | ||
| Abdominal | 2.88 (1.49–5.59) | 1.058 | 11 |
| Intrathoracic | 12.20 (4.61–32.28) | 2.501 | 25 |
| Intraoperative blood loss ≥100 mL | 3.00 (1.64–5.50) | 1.100 | 11 |
| Postoperative fasting blood glucose >6.1 mmol/L | 2.60 (1.91–3.54) | 0.956 | 10 |
| Postoperative albumin <35 g/L | 4.21 (2.24–7.92) | 1.438 | 14 |
| Postoperative ventilation | 7.20 (1.96–26.45) | 1.975 | 20 |
PPCs: postoperative pulmonary complications; SpO2: saturation of peripheral oxygen.
Figure 2Receiver operating characteristic (ROC) curves drawn for the current model and previous index (Canet's) in cohort 2. c-statistic for the area under the ROC curve (AUC) = 0.90 (95% CI, 0.86 to 0.94) drawn from the current index and AUC = 0.76 (95% CI, from 0.68 to 0.83) drawn from the previous index.
Distribution of PPCs risk index scores in patients.
| Risk class | ||||
|---|---|---|---|---|
| Low risk | Intermediate risk | High risk | Extremely high risk | |
| Cohort 1, | 672 (74.5) | 127 (14.1) | 67 (7.4) | 36 (4.0) |
| Cohort 2, | 577 (74.8) | 110 (14.3) | 54 (7.0) | 30 (3.9) |
| Rate of PPCs in cohort 1, | 21 (3.1) | 22 (17.3) | 38 (56.7) | 31 (86.1) |
| Rate of PPCs in cohort 2, | 5 (0.9) | 17 (15.5) | 12 (22.2) | 17 (56.7) |
PPCs: postoperative pulmonary complications.
Interventions to reduce the risk of PPCs.
|
| |
| A careful history taking and physical examination | |
| Encourage cessation of smoking for at least 2 months | |
| Appropriate use of antibiotics and delay surgery if respiratory infection is present | |
| Recommend a regular exercise program (e.g., walking, upper limb exercises, swimming, pool exercises, etc.) | |
| Treat patients with established asthma with inhaled corticosteroids | |
| Treat patients with established COPD with regular bronchodilators | |
|
| |
|
| |
| Substitute less ambitious procedure for upper abdominal or thoracic surgery when possible | |
| Minimize blood loss | |
| Limit duration of surgery to less than 3 hr | |
| Whenever possible, use spinal or epidural anesthesia | |
|
| |
|
| |
| Recommend regular lung expansion modalities such as deep breathing exercises | |
| Perform selective decompression of abdominal contents using nasogastric tube if patient is experiencing symptomatic gastric | |
| As soon as possible after surgery, have the patient sit up in a chair | |
PPCs: postoperative pulmonary complications; COPD: chronic obstructive pulmonary disease.